Cargando…

Loss, Gain and Altered Function of GlyR α2 Subunit Mutations in Neurodevelopmental Disorders

Glycine receptors (GlyRs) containing the α2 subunit govern cell fate, neuronal migration and synaptogenesis in the developing cortex and spinal cord. Rare missense variants and microdeletions in the X-linked GlyR α2 subunit gene (GLRA2) have been associated with human autism spectrum disorder (ASD),...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xiumin, Wilson, Katie A., Schaefer, Natascha, De Hayr, Lachlan, Windsor, Mark, Scalais, Emmanuel, van Rijckevorsel, Germaine, Stouffs, Katrien, Villmann, Carmen, O’Mara, Megan L., Lynch, Joseph W., Harvey, Robert J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9103196/
https://www.ncbi.nlm.nih.gov/pubmed/35571374
http://dx.doi.org/10.3389/fnmol.2022.886729
_version_ 1784707503862317056
author Chen, Xiumin
Wilson, Katie A.
Schaefer, Natascha
De Hayr, Lachlan
Windsor, Mark
Scalais, Emmanuel
van Rijckevorsel, Germaine
Stouffs, Katrien
Villmann, Carmen
O’Mara, Megan L.
Lynch, Joseph W.
Harvey, Robert J.
author_facet Chen, Xiumin
Wilson, Katie A.
Schaefer, Natascha
De Hayr, Lachlan
Windsor, Mark
Scalais, Emmanuel
van Rijckevorsel, Germaine
Stouffs, Katrien
Villmann, Carmen
O’Mara, Megan L.
Lynch, Joseph W.
Harvey, Robert J.
author_sort Chen, Xiumin
collection PubMed
description Glycine receptors (GlyRs) containing the α2 subunit govern cell fate, neuronal migration and synaptogenesis in the developing cortex and spinal cord. Rare missense variants and microdeletions in the X-linked GlyR α2 subunit gene (GLRA2) have been associated with human autism spectrum disorder (ASD), where they typically cause a loss-of-function via protein truncation, reduced cell-surface trafficking and/or reduced glycine sensitivity (e.g., GLRA2Δex8-9 and extracellular domain variants p.N109S and p.R126Q). However, the GlyR α2 missense variant p.R323L in the intracellular M3-M4 domain results in a gain-of-function characterized by slower synaptic decay times, longer duration active periods and increases in channel conductance. This study reports the functional characterization of four missense variants in GLRA2 associated with ASD or developmental disorders (p.V-22L, p.N38K, p.K213E, p.T269M) using a combination of bioinformatics, molecular dynamics simulations, cellular models of GlyR trafficking and electrophysiology in artificial synapses. The GlyR α2(V–22L) variant resulted in altered predicted signal peptide cleavage and a reduction in cell-surface expression, suggestive of a partial loss-of-function. Similarly, GlyR α2(N38K) homomers showed reduced cell-surface expression, a reduced affinity for glycine and a reduced magnitude of IPSCs in artificial synapses. By contrast, GlyR α2(K213E) homomers showed a slight reduction in cell-surface expression, but IPSCs were larger, with faster rise/decay times, suggesting a gain-of-function. Lastly, GlyR α2(T269M) homomers exhibited a high glycine sensitivity accompanied by a substantial leak current, suggestive of an altered function that could dramatically enhance glycinergic signaling. These results may explain the heterogeneity of clinical phenotypes associated with GLRA2 mutations and reveal that missense variants can result in a loss, gain or alteration of GlyR α2 function. In turn, these GlyR α2 missense variants are likely to either negatively or positively deregulate cortical progenitor homeostasis and neuronal migration in the developing brain, leading to changes in cognition, learning, and memory.
format Online
Article
Text
id pubmed-9103196
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-91031962022-05-14 Loss, Gain and Altered Function of GlyR α2 Subunit Mutations in Neurodevelopmental Disorders Chen, Xiumin Wilson, Katie A. Schaefer, Natascha De Hayr, Lachlan Windsor, Mark Scalais, Emmanuel van Rijckevorsel, Germaine Stouffs, Katrien Villmann, Carmen O’Mara, Megan L. Lynch, Joseph W. Harvey, Robert J. Front Mol Neurosci Neuroscience Glycine receptors (GlyRs) containing the α2 subunit govern cell fate, neuronal migration and synaptogenesis in the developing cortex and spinal cord. Rare missense variants and microdeletions in the X-linked GlyR α2 subunit gene (GLRA2) have been associated with human autism spectrum disorder (ASD), where they typically cause a loss-of-function via protein truncation, reduced cell-surface trafficking and/or reduced glycine sensitivity (e.g., GLRA2Δex8-9 and extracellular domain variants p.N109S and p.R126Q). However, the GlyR α2 missense variant p.R323L in the intracellular M3-M4 domain results in a gain-of-function characterized by slower synaptic decay times, longer duration active periods and increases in channel conductance. This study reports the functional characterization of four missense variants in GLRA2 associated with ASD or developmental disorders (p.V-22L, p.N38K, p.K213E, p.T269M) using a combination of bioinformatics, molecular dynamics simulations, cellular models of GlyR trafficking and electrophysiology in artificial synapses. The GlyR α2(V–22L) variant resulted in altered predicted signal peptide cleavage and a reduction in cell-surface expression, suggestive of a partial loss-of-function. Similarly, GlyR α2(N38K) homomers showed reduced cell-surface expression, a reduced affinity for glycine and a reduced magnitude of IPSCs in artificial synapses. By contrast, GlyR α2(K213E) homomers showed a slight reduction in cell-surface expression, but IPSCs were larger, with faster rise/decay times, suggesting a gain-of-function. Lastly, GlyR α2(T269M) homomers exhibited a high glycine sensitivity accompanied by a substantial leak current, suggestive of an altered function that could dramatically enhance glycinergic signaling. These results may explain the heterogeneity of clinical phenotypes associated with GLRA2 mutations and reveal that missense variants can result in a loss, gain or alteration of GlyR α2 function. In turn, these GlyR α2 missense variants are likely to either negatively or positively deregulate cortical progenitor homeostasis and neuronal migration in the developing brain, leading to changes in cognition, learning, and memory. Frontiers Media S.A. 2022-04-29 /pmc/articles/PMC9103196/ /pubmed/35571374 http://dx.doi.org/10.3389/fnmol.2022.886729 Text en Copyright © 2022 Chen, Wilson, Schaefer, De Hayr, Windsor, Scalais, van Rijckevorsel, Stouffs, Villmann, O’Mara, Lynch and Harvey. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Chen, Xiumin
Wilson, Katie A.
Schaefer, Natascha
De Hayr, Lachlan
Windsor, Mark
Scalais, Emmanuel
van Rijckevorsel, Germaine
Stouffs, Katrien
Villmann, Carmen
O’Mara, Megan L.
Lynch, Joseph W.
Harvey, Robert J.
Loss, Gain and Altered Function of GlyR α2 Subunit Mutations in Neurodevelopmental Disorders
title Loss, Gain and Altered Function of GlyR α2 Subunit Mutations in Neurodevelopmental Disorders
title_full Loss, Gain and Altered Function of GlyR α2 Subunit Mutations in Neurodevelopmental Disorders
title_fullStr Loss, Gain and Altered Function of GlyR α2 Subunit Mutations in Neurodevelopmental Disorders
title_full_unstemmed Loss, Gain and Altered Function of GlyR α2 Subunit Mutations in Neurodevelopmental Disorders
title_short Loss, Gain and Altered Function of GlyR α2 Subunit Mutations in Neurodevelopmental Disorders
title_sort loss, gain and altered function of glyr α2 subunit mutations in neurodevelopmental disorders
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9103196/
https://www.ncbi.nlm.nih.gov/pubmed/35571374
http://dx.doi.org/10.3389/fnmol.2022.886729
work_keys_str_mv AT chenxiumin lossgainandalteredfunctionofglyra2subunitmutationsinneurodevelopmentaldisorders
AT wilsonkatiea lossgainandalteredfunctionofglyra2subunitmutationsinneurodevelopmentaldisorders
AT schaefernatascha lossgainandalteredfunctionofglyra2subunitmutationsinneurodevelopmentaldisorders
AT dehayrlachlan lossgainandalteredfunctionofglyra2subunitmutationsinneurodevelopmentaldisorders
AT windsormark lossgainandalteredfunctionofglyra2subunitmutationsinneurodevelopmentaldisorders
AT scalaisemmanuel lossgainandalteredfunctionofglyra2subunitmutationsinneurodevelopmentaldisorders
AT vanrijckevorselgermaine lossgainandalteredfunctionofglyra2subunitmutationsinneurodevelopmentaldisorders
AT stouffskatrien lossgainandalteredfunctionofglyra2subunitmutationsinneurodevelopmentaldisorders
AT villmanncarmen lossgainandalteredfunctionofglyra2subunitmutationsinneurodevelopmentaldisorders
AT omarameganl lossgainandalteredfunctionofglyra2subunitmutationsinneurodevelopmentaldisorders
AT lynchjosephw lossgainandalteredfunctionofglyra2subunitmutationsinneurodevelopmentaldisorders
AT harveyrobertj lossgainandalteredfunctionofglyra2subunitmutationsinneurodevelopmentaldisorders